143 related articles for article (PubMed ID: 12120230)
21. International registries of families at high risk of pancreatic cancer.
Greenhalf W; Malats N; Nilsson M; Bartsch D; Neoptolemos J
Pancreatology; 2008; 8(6):558-65. PubMed ID: 18818508
[TBL] [Abstract][Full Text] [Related]
22. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
[TBL] [Abstract][Full Text] [Related]
23. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.
Lynch HT; Deters CA; Snyder CL; Lynch JF; Villeneuve P; Silberstein J; Martin H; Narod SA; Brand RE
Cancer Genet Cytogenet; 2005 Apr; 158(2):119-25. PubMed ID: 15796958
[TBL] [Abstract][Full Text] [Related]
24. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
25. Familial Pancreatic Cancer and Surveillance of High-Risk Individuals.
Matsubayashi H; Takaori K; Morizane C; Kiyozumi Y
Gut Liver; 2019 Sep; 13(5):498-505. PubMed ID: 30917631
[TBL] [Abstract][Full Text] [Related]
26. Clinical and pathologic features of familial pancreatic cancer.
Humphris JL; Johns AL; Simpson SH; Cowley MJ; Pajic M; Chang DK; Nagrial AM; Chin VT; Chantrill LA; Pinese M; Mead RS; Gill AJ; Samra JS; Kench JG; Musgrove EA; Tucker KM; Spigelman AD; Waddell N; Grimmond SM; Biankin AV;
Cancer; 2014 Dec; 120(23):3669-75. PubMed ID: 25313458
[TBL] [Abstract][Full Text] [Related]
27. Familial pancreatic cancer--current knowledge.
Bartsch DK; Gress TM; Langer P
Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):445-53. PubMed ID: 22664588
[TBL] [Abstract][Full Text] [Related]
28. PALB2 analysis in BRCA2-like families.
Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
[TBL] [Abstract][Full Text] [Related]
29. Hereditary pancreatic cancer.
Lynch HT; Brand RE; Deters CA; Shaw TG; Lynch JF
Pancreatology; 2001; 1(5):466-71. PubMed ID: 12120226
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
Goldstein AM; Fraser MC; Struewing JP; Hussussian CJ; Ranade K; Zametkin DP; Fontaine LS; Organic SM; Dracopoli NC; Clark WH
N Engl J Med; 1995 Oct; 333(15):970-4. PubMed ID: 7666916
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Murphy KM; Brune KA; Griffin C; Sollenberger JE; Petersen GM; Bansal R; Hruban RH; Kern SE
Cancer Res; 2002 Jul; 62(13):3789-93. PubMed ID: 12097290
[TBL] [Abstract][Full Text] [Related]
32. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
[TBL] [Abstract][Full Text] [Related]
33. Familial pancreatic cancer.
Hruban RH; Petersen GM; Goggins M; Tersmette AC; Offerhaus GJ; Falatko F; Yeo CJ; Kern SE
Ann Oncol; 1999; 10 Suppl 4():69-73. PubMed ID: 10436789
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Chaffee KG; Oberg AL; McWilliams RR; Majithia N; Allen BA; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Petersen GM
Genet Med; 2018 Jan; 20(1):119-127. PubMed ID: 28726808
[TBL] [Abstract][Full Text] [Related]
35. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
[TBL] [Abstract][Full Text] [Related]
36. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
Klein AP; Brune KA; Petersen GM; Goggins M; Tersmette AC; Offerhaus GJ; Griffin C; Cameron JL; Yeo CJ; Kern S; Hruban RH
Cancer Res; 2004 Apr; 64(7):2634-8. PubMed ID: 15059921
[TBL] [Abstract][Full Text] [Related]
37. Familial melanoma, pancreatic cancer and germline CDKN2A mutations.
Goldstein AM
Hum Mutat; 2004 Jun; 23(6):630. PubMed ID: 15146471
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome.
Rulyak SJ; Brentnall TA; Lynch HT; Austin MA
Cancer; 2003 Aug; 98(4):798-804. PubMed ID: 12910525
[TBL] [Abstract][Full Text] [Related]
39. Hereditary pancreatic cancer: a clinical perspective.
Greer JB; Lynch HT; Brand RE
Best Pract Res Clin Gastroenterol; 2009; 23(2):159-70. PubMed ID: 19414143
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a major gene influencing risk of pancreatic cancer.
Klein AP; Beaty TH; Bailey-Wilson JE; Brune KA; Hruban RH; Petersen GM
Genet Epidemiol; 2002 Aug; 23(2):133-49. PubMed ID: 12214307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
